Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,773
Closed -$658K 99
2017
Q3
$658K Hold
10,773
0.34% 77
2017
Q2
$659K Sell
10,773
-420
-4% -$25.6K 0.35% 69
2017
Q1
$679K Sell
11,193
-995
-8% -$60.4K 0.36% 67
2016
Q4
$685K Buy
12,188
+2,620
+27% +$153K 0.37% 66
2016
Q3
$570K Hold
9,568
0.33% 70
2016
Q2
$526K Hold
9,568
0.32% 71
2016
Q1
$483K Sell
9,568
-419
-4% -$20.5K 0.27% 75
2015
Q4
$503K Sell
9,987
-629
-6% -$31.7K 0.28% 74
2015
Q3
$500K Sell
10,616
-210
-2% -$11.2K 0.29% 73
2015
Q2
$588K Sell
10,826
-524
-5% -$29.4K 0.31% 71
2015
Q1
$623K Hold
11,350
0.33% 69
2014
Q4
$615K Sell
11,350
-4,401
-28% -$245K 0.35% 65
2014
Q3
$891K Sell
15,751
-90
-0.6% -$5.05K 0.49% 60
2014
Q2
$874K Sell
15,841
-1,587
-9% -$86.6K 0.48% 58
2014
Q1
$944K Sell
17,428
-524
-3% -$27.1K 0.57% 55
2013
Q4
$857K Sell
17,952
-8,594
-32% -$393K 0.51% 58
2013
Q3
$1.21M Buy
26,546
+7,965
+43% +$364K 0.8% 50
2013
Q2
$824K Buy
+18,581
New +$830K 0.59% 59

Other funds holding MRK

Laurel Grove Capital's MRK Position: Q4 2017 in Review

Laurel Grove Capital sold out of Merck (MRK) in Q4 2017, closing a stake of 10,773 shares — an estimated $658K sold.

Laurel Grove Capital first reported a position in MRK in Q2 2013 and held it in 18 quarters. The position peaked at $1.21M in Q3 2013. 2,009 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Laurel Grove Capital reported no remaining Merck position as of Q4 2017 after selling out during the quarter.
  • Laurel Grove Capital sold 10,773 Merck shares in Q4 2017, an estimated $658K.
  • Laurel Grove Capital first reported a position in Merck in Q2 2013 and held it in 18 quarters.
  • Laurel Grove Capital's Merck position peaked at $1.21M in Q3 2013.
  • 2,009 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Laurel Grove Capital's 13F filing for Q4 2017, filed 23 Jan 2018.